| PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer C Pantelidou, O Sonzogni, M De Oliveria Taveira, AK Mehta, A Kothari, ... Cancer discovery 9 (6), 722-737, 2019 | 511 | 2019 |
| Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer AK Mehta, EM Cheney, CA Hartl, C Pantelidou, M Oliwa, JA Castrillon, ... Nature cancer 2 (1), 66-82, 2021 | 148 | 2021 |
| Dysregulation in actin cytoskeletal organization drives increased stiffness and migratory persistence in polyploidal giant cancer cells B Xuan, D Ghosh, EM Cheney, EM Clifton, MR Dawson Scientific reports 8 (1), 11935, 2018 | 60 | 2018 |
| Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer CA Hartl, A Bertschi, RB Puerto, C Andresen, EM Cheney, EA Mittendorf, ... Journal for ImmunoTherapy of Cancer 7, 1-17, 2019 | 36 | 2019 |
| Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer JC Lal, MG Townsend, AK Mehta, M Oliwa, E Miller, A Sotayo, E Cheney, ... Breast Cancer Research 23, 1-24, 2021 | 16 | 2021 |
| 860 Targeting immunosuppressive macrophages overcomes PARP-inhibitor resistance in BRCA1-associated triple-negative breast cancer A Mehta, E Cheney, C Hartl, C Pantelidou, M Oliwa, J Castrillon, JR Lin, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Use of murine models to identify tumor immune components that correlate with response to immunotherapy in breast cancer JA Castrillon, AK Mehta, E Cheney, E Miller, A Sotayo, EA Mittendorf, ... | | 2020 |
| Abstract A81: Identifying cellular immune components that correlate with response to immunotherapy in breast cancer using murine models AK Mehta, JA Castrillion, A Sotayo, EA Mittendorf, AG Letai, JL Guerriero, ... Cancer Immunology Research 8 (3_Supplement), A81-A81, 2020 | | 2020 |
| PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing … AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 83-83, 2020 | | 2020 |
| Identifying cellular immune components that correlate with response to immunotherapy in breast cancer using murine models. AK Mehta, JA Castrillion, A Sotayo, EA Mittendorf, AG Letai, JL Guerriero, ... CANCER IMMUNOLOGY RESEARCH 8 (3), 71-72, 2020 | | 2020 |
| Abstract A105: PARP inhibition modulates the infiltration, phenotype, and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented … AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, CA Hartl, ... Cancer Immunology Research 8 (3_Supplement), A105-A105, 2020 | | 2020 |
| Abstract P5-04-01: PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be … JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ... Cancer Research 80 (4_Supplement), P5-04-01-P5-04-01, 2020 | | 2020 |
| PARP inhibition modulates the infiltration, phenotype and function of tumor-associated macrophages (TAMs) in BRCA-associated breast cancer and can be augmented by harnessing … JL Guerriero, AK Mehta, EM Cheney, JA Castrillon, JR Lin, MO Taveira, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Like this A Hanes, MR Dawson, D Wirtz, J Fu, EM Krauland, B Xuan, D Ghosh, ... US Patent App 15, 988,615, 2015 | | 2015 |
